CAPR - Capricor Therapeutics Inc's (CAPR) CEO Linda Marbán on Q3 2020 Results - Earnings Call Transcript

Capricor Therapeutics, Inc. (CAPR) Q3 2020 Earnings Conference Call November 12, 2020 04:30 pm ET Company Participants A.J. Bergmann - Chief Financial Officer Linda Marbán - President, Chief Executive Officer and Director Steve Gould - Executive Consultant Conference Call Participants Emanuela Branchetti - H.C. Wainwright Jason McCarthy - Maxim Group Alan Leong - BioWatch News Presentation Operator Greetings, and welcome to the Capricor Therapeutics Inc Third Quarter 2020 Earnings Call. [Operator Instructions]. As a reminder, this conference is being recorded. It is now pleasure to introduce your host, CFO, A.J. Bergmann. Thank you, you may begin. A.J. Bergmann Thank you. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our product candidates, our future Research & Development plan, including our anticipated conduct and timing

For further details see:

Capricor Therapeutics, Inc's (CAPR) CEO Linda Marbán on Q3 2020 Results - Earnings Call Transcript